Wolverine Trading’s Arcturus Therapeutics ARCT Stock Holding History

Wolverine Trading’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$274K	Buy	14,610 +760	+5%	+$12.2K	﹤0.01%	4514
2025 Q2	$185K	Buy	+13,850	New	+$164K	﹤0.01%	3954
2021 Q2	–	Sell	-6,034	Closed	-$234K	–	5877
2021 Q1	$234K	Sell	6,034 -5,000	-45%	-$298K	﹤0.01%	4826
2020 Q4	$515K	Sell	11,034 -927	-8%	-$62.8K	﹤0.01%	3134
2020 Q3	$511K	Sell	11,961 -8,115	-40%	-$403K	﹤0.01%	2793
2020 Q2	$943K	Buy	+20,076	New	+$692K	﹤0.01%	2058

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Wolverine Trading's ARCT Position: Q3 2025 in Review

Wolverine Trading increased its Arcturus Therapeutics (ARCT) stake by 5.5% in Q3 2025, buying an estimated $12.2K and bringing the position to 14,610 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Wolverine Trading first reported a position in ARCT in Q2 2020 and has held it in 6 quarters since. The position peaked at $943K in Q2 2020. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

Wolverine Trading held 14,610 shares of Arcturus Therapeutics worth $274K as of Q3 2025.
Wolverine Trading bought 760 Arcturus Therapeutics shares in Q3 2025, an estimated $12.2K.
Arcturus Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4514 holding.
Wolverine Trading first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 6 quarters since.
Wolverine Trading's Arcturus Therapeutics position peaked at $943K in Q2 2020.
136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.